Showing results (421-430 of 429) with videos related to
Sort By:
Pageof 43
You have reached the last page of results.This site can display upto 429 results.
The Breast Journal|June 24, 2026
HER2-Ultralow: Prevalence, Characteristics, and Treatment Choices Among Advanced Breast Cancer Patients With Tumors Initially Scored as IHC 0Anushree R Iyengar, Erinn P Downs, Sandhya Mehta, et al.Bioorganic & Medicinal Chemistry Letters|March 4, 2021
Discovery of CYR715: A novel carboxylic acid-containing soluble guanylate cyclase stimulatorGlen R Rennie, Timothy C Barden, Sylvie G Bernier, et al.Frontiers in Pharmacology|June 10, 2021
The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative DiseasesSusana S Correia, Rajesh R Iyengar, Peter Germano, et al.Bioorganic & Medicinal Chemistry Letters|January 20, 2007
An evaluation of 3,4-methylenedioxy phenyl replacements in the aminopiperidine chromone class of MCHr1 antagonistsRajesh R Iyengar, John K Lynch, Mathew M Mulhern, et al.Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Identification of diamino chromone-2-carboxamides as MCHr1 antagonists with minimal hERG channel activityAndrew S Judd, Andrew J Souers, Dariusz Wodka, et al.Journal of Medicinal Chemistry|January 11, 2008
Validation of diacyl glycerolacyltransferase I as a novel target for the treatment of obesity and dyslipidemia using a potent and selective small molecule inhibitorGang Zhao, Andrew J Souers, Martin Voorbach, et al.Bioorganic & Medicinal Chemistry Letters|December 26, 2006
Constrained 7-fluorocarboxychromone-4-aminopiperidine based Melanin-concentrating hormone receptor 1 antagonists: the effects of chirality on substituted indan-1-ylaminesAndrew J Souers, Rajesh R Iyengar, Andrew S Judd, et al.Cell Metabolism|November 26, 2025
A metabolic atlas of mouse agingSteven E Pilley, Dominik Awad, Djakim Latumalea, et al.Cardiovascular and Interventional Radiology|July 5, 2022
Dragon 1 Protocol Manuscript: Training, Accreditation, Implementation and Safety Evaluation of Portal and Hepatic Vein Embolization (PVE/HVE) to Accelerate Future Liver Remnant (FLR) HypertrophyR Korenblik, B Olij, L A Aldrighetti, et al.Pageof 43